Cargando…

Interleukin-1/6 Blockade for the Treatment of Severe Steroid-Refractory BNT162b2 Vaccine-Induced Adult-Onset Still’s Disease

INTRODUCTION: Several immune-mediated side effects have been reported with COVID-19 vaccines, including myocarditis. CASE DESCRIPTION: A 27-year-old woman with a past medical history of mild COVID-19, developed adult-onset Still’s disease (AOSD) with salmon-pink flagellate erythema, polyarthritis, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hugues, Benjamin, Ben Amer, Hakim, Bril, Floriane, Groh, Matthieu, Huang, Florent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SMC Media Srl 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451514/ https://www.ncbi.nlm.nih.gov/pubmed/36093302 http://dx.doi.org/10.12890/2022_003469

Ejemplares similares

Adult-onset Still’s Disease after BNT162b2 mRNA COVID-19 Vaccine
por: Park, Seong Yeon, et al.
Publicado: (2021)

Macrophage activation syndrome in a patient with adult-onset Still’s disease following first COVID-19 vaccination with BNT162b2
por: Muench, Frédéric, et al.
Publicado: (2021)

Refractory Adult Onset Still’s Disease
por: Sulaiman, Wahinuddin, et al.
Publicado: (2017)

Steroid-responsive aseptic meningitis after BNT162b2 SARS-CoV-2 vaccine
por: Reis Carneiro, D., et al.
Publicado: (2022)

Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
por: Reiter, Rieke, et al.
Publicado: (2022)

Successful treatment with tacrolimus of refractory adult-onset Still's disease
por: Ohe, Masashi, et al.
Publicado: (2014)

Efficacy of Baricitinib in Patients with Refractory Adult-Onset Still’s Disease
por: Sun, Ziyi, et al.
Publicado: (2023)

Anti-Interleukin-1 Agents in Adult Onset Still's Disease
por: Giampietro, Cecilia, et al.
Publicado: (2012)

Adult-Onset Acute Disseminated Encephalomyelitis Refractory to Steroids
por: AlZeera, Abdulla J, et al.
Publicado: (2021)

Pfizer SARS-CoV-2 BNT162b2 mRNA vaccination (BNT162b2) has no adverse effect on elective oocyte cryopreservation outcomes
por: Karavani, Gilad, et al.
Publicado: (2022)

Acquired hemophilia A in a patient with adult‐onset Still's disease: Successful treatment with steroids
por: Chebbi, Donia, et al.
Publicado: (2023)

Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents
por: Reis, Ben Y., et al.
Publicado: (2021)

Successful Treatment with Intravenous Cyclophosphamide for Refractory Adult-Onset Still's Disease
por: Tsuji, Yoshika, et al.
Publicado: (2015)

Myocarditis as the Initial Presentation of a Refractory Adult-Onset Still’s Disease
por: Pina Gonçalves, Nuno, et al.
Publicado: (2022)

Neutralizing Activity of BNT162b2-Elicited Serum
por: Liu, Yang, et al.
Publicado: (2021)

BNT162b2 vaccine for prevention of COVID-19
Publicado: (2021)

Boosting BNT162b2 vaccine efficacy in CLL
por: Bhat, Seema A., et al.
Publicado: (2022)

Erythema Multiforme after BNT162b2 Vaccination
por: Katayama, Sho, et al.
Publicado: (2022)

Mucosal Interleukin‐10 depletion in steroid‐refractory Crohn's disease patients
por: Carrasco, Anna, et al.
Publicado: (2022)

Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination
por: Lim, Xin Rong, et al.
Publicado: (2021)

Longitudinal Analysis of SARS-CoV-2-Specific Cellular and Humoral Immune Responses and Breakthrough Infection following BNT162b2/BNT162b2/BNT162b2 and ChAdOx1/ChAdOx1/BNT162b2 Vaccination: A Prospective Cohort in Naive Healthcare Workers
por: Ko, Geon Young, et al.
Publicado: (2023)

Immunogenicity of a BNT162b2 vaccine booster in health-care workers
por: Saiag, Esther, et al.
Publicado: (2021)

1559O Efficacy and toxicity of BNT162b2 vaccine in cancer patients
por: Ben-Aharon, I., et al.
Publicado: (2021)

Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?
por: Palombi, Massimiliano, et al.
Publicado: (2016)

Posterior ocular manifestations following BNT162b2 mRNA COVID-19 vaccine: a case series
por: Pillar, Shani, et al.
Publicado: (2022)

Different Features of Interleukin-37 and Interleukin-18 as Disease Activity Markers of Adult-Onset Still’s Disease
por: Nam, Seoung Wan, et al.
Publicado: (2021)

A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
por: Li, Ting, et al.
Publicado: (2017)

Ruxolitinib for Refractory Macrophage Activation Syndrome Complicating Adult-Onset Still’s Disease
por: Levy, Ofer, et al.
Publicado: (2022)

Interleukin-37 is increased in adult-onset Still’s disease and associated with disease activity
por: Chi, Huihui, et al.
Publicado: (2018)

BNT-162b1: Stevens-Johnson syndrome: case report
Publicado: (2021)

Waning Immunity after the BNT162b2 Vaccine in Israel
por: Goldberg, Yair, et al.
Publicado: (2021)

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
por: Mevorach, Dror, et al.
Publicado: (2022)

Acute interstitial nephritis after vaccination with BNT162b2
por: Rieckmann, Sonja, et al.
Publicado: (2022)

Effectiveness of BNT162b2 against COVID-19 in adolescents
por: Powell, Annabel A, et al.
Publicado: (2022)

Acute myocarditis following administration of BNT162b2 vaccine
por: Habib, Mhd Baraa, et al.
Publicado: (2021)

Beyond neutralization for BNT162b2 mRNA vaccination
por: Damani-Yokota, Payal, et al.
Publicado: (2021)

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
por: Witberg, Guy, et al.
Publicado: (2022)

Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine
por: Gallais, Floriane, et al.
Publicado: (2022)

Outbreak of SARS-CoV-2 infection in a long-term care facility after COVID-19 BNT162b2 mRNA vaccination
por: Martinot, Martin, et al.
Publicado: (2021)

Évaluation de l'immunogénicité après vaccination COVID-19 hétérologue ChAdOx1-nCoV19/BNT162b2 et homologue BNT162b2/BNT162b2– Cohorte ANRS0001S COV-POPART
por: Lachâtre, M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_20ukq2p5dma10glssg3dmr0l6p